36 results
8-K
SABS
SAB Biotherapeutics Inc
6 Jun 22
Other Events
1:35pm
Specialty R&D at Teva Pharmaceuticals, where she led innovative drug development focused on delivering on a broad portfolio of immunology, respiratory … ; Associate Vice President and subsequently Vice President, Immuno-Inflammation, Global R&D Clinical Development; and Senior Medical Director
8-K
EX-99.1
SABS
SAB Biotherapeutics Inc
6 Jun 22
Other Events
1:35pm
to joining SAB, Dr. Kropotova was the Therapeutic Area Head at Global Specialty R&D at Teva Pharmaceuticals, where she led innovative drug development focused … President, Immuno-Inflammation, Global R&D Clinical Development; and Senior Medical Director, Respiratory, Allergy & Anti-Infectives. She served
8-K
EX-99.1
SABS
SAB Biotherapeutics Inc
22 Nov 21
SAB Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Company Update
7:42am
$10.8 million as compared to $13.5 million as of September 30, 2020.
Research and Development (R&D) Expenses – R&D expenses were $46.5 million
424B3
q7ptit8vse
6 Jun 22
Prospectus supplement
7:02pm
8-K
EX-99.1
pk89rffhljm15jqf60
29 Mar 24
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
9:35am
8-K
EX-99.1
tw9sm
19 Jan 24
Regulation FD Disclosure
4:21pm
UPLOAD
hhpxwpj80io
29 Jul 21
Letter from SEC
12:00am
425
lnehl
21 Jul 21
Business combination disclosure
6:04am
8-K
EX-99.1
n61brqpq75jxv0 96cm7
11 Jul 22
Submission of Matters to a Vote of Security Holders
9:11am
8-K
EX-99.1
10emdg
5 Jul 22
Regulation FD Disclosure
4:31pm
8-K
EX-99.1
4ahr01n3
23 Sep 22
Regulation FD Disclosure
8:59am
8-K
EX-99.1
rs14k o41v
21 Nov 22
Regulation FD Disclosure
4:46pm
8-K
EX-99.1
7m5d71l
31 Mar 23
SAB Biotherapeutics Provides Company Update for Full Year 2022
5:12pm
CORRESP
u29 2bdklcjmcms1rrrf
17 Aug 21
Correspondence with SEC
12:00am
8-K
EX-99.1
7tp7z nmzyze3u
22 Jun 21
Entry into a Material Definitive Agreement
9:05am
425
EX-99.1
lctdg
22 Jun 21
Business combination disclosure
9:03am
10-K
uabc nkzyjcvnfd
2 Apr 21
Annual report
4:57pm